Gene therapy advances spark testing for sickle cell cure
Researchers at Thomas Jefferson University report a synthetic molecule, a chimera repair tool, corrects the sickle cell mutation in lab cells and could enter human testing within 12 months after FDA discussions. The approach aims to fix a single nucleotide error to restore normal red blood cell function.
MENTIONED IN THIS ARTICLE
Washington
Thomas Jefferson University
Philadelphia
Eric B. Kmiec
Jefferson
Gaucher
Kmiec
Food and Drug Administration
Also Mentioned on This Page
New Way
Donald B. Kohn
The
Children’s Hospital
Los Angeles
Science
Furniture Factory
Rans
Dan Williams Millworks
Cy Ae
S. Big Springs Midland, TX
Urniture
Furniture
Lundy
Michigan
Laskey
Kent Street
Morgan
Water Wonderland
Hwy
Bidgs
Yehae
Wolfe
Texas
NMS UU
St. Augustine
Midland
W. Scharbauer
Odessa
Andrews Hwy
Peru
Levi's
Arizona Jean CO
Orig
Skorts & Skirts Orig
Bras Orig
Misses & Juniors
Arizona
Jcpenney Company, Inc
To Ad
Umterwine
Sss
Siweys Exchiies
South Pole
Hunt Club
LEE
Saley
Levi's Shorts
Boys & Girls
Hunchback Apparel
NFL
NIKE
Orr
Brians
Jcpenney
Permian Mali